Advertisement
Advertisement

HROW

HROW logo

Harrow Inc

34.26
USD
-0.17
-0.49%
Dec 20, 15:59 UTC -5
Closed
...

Harrow Inc Profile

About

Harrow Inc. is an eyecare pharmaceutical company. It engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products principally for the U.S. market. Harrow Inc., formerly known as Harrow Health Inc., is based in NASHVILLE, Tenn.

Info & Links

CEO

Mark L. Baum

Headquarters

102 Woodmont Blvd., Suite 610
Nashville, TN 37205, UNITED STATES

Auditor

KMJ Corbin & Company LLP

Share holders

67

Employees

315

Harrow Inc Statistics

Valuation Measures

Market Capitalization2

1.22B

Enterprise Value

1.33B

Enterprise Value/EBITDA(ttm)

159.58

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

7.25

Price to Book(mrq)

21.20

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

72.10%

Operating Margin(ttm)

-16.60%

Profit Margin(ttm)

-21.54%

Return on Equity(ttm)

-45.57%

Return on Invested Capital(ttm)

-13.55%

Return on Assets(ttm)

-8.87%

Income Statement

Revenue(ttm)

169.14M

Revenue Per Share(ttm)

4.75

Gross Profit(ttm)

122.73M

EBITDA(ttm)3

8.36M

Net Income Available to Common(ttm)

-33.41M

Diluted EPS(ttm)

-0.94

Share Statistics

Beta (5Y Monthly)

0.69

52-Week Change

254.29%

S&P 500 52-Week Change

24.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

35.61M

Dividend Yield

0.00%

Float4

30.75M

% Held by Insiders

13.67%

% Held by Institutions

72.76%

Balance Sheet

Total Cash(mrq)

72.60M

Total Cash Per Share(mrq)

2.04

Total Debt(mrq)

186.06M

Total Debt/Equity(mrq)

322.90%

Current Ratio(mrq)

1.55%

Quick Ratio(mrq)

1.44%

Book Value Per Share(mrq)

1.62

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.12

Free Cash Flow(ytd)

-5.46M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement